<div id="readability-page-1">Focused Wealth Management Inc boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 161.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,756 shares of the healthcare conglomerate's stock after purchasing an additional 4,175 shares during the period. Focused Wealth Management Inc's holdings in UnitedHealth Group were worth $2,333,000 at the end of the most recent reporting period.<div>Get UnitedHealth Group alerts:</div><ul><li>The Top 3 Investment Themes That Will Dominate 2026</li></ul>Several other large investors have also added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate's stock valued at $6,624,411,000 after purchasing an additional 675,075 shares in the last quarter. Norges Bank purchased a new stake in UnitedHealth Group in the second quarter worth about $3,837,207,000. Dodge &amp; Cox grew its holdings in shares of UnitedHealth Group by 117.7% during the 2nd quarter. Dodge &amp; Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after acquiring an additional 4,730,192 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 6.1% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 7,502,469 shares of the healthcare conglomerate's stock valued at $2,340,346,000 after purchasing an additional 432,084 shares during the period. Finally, Amundi grew its stake in UnitedHealth Group by 33.8% in the second quarter. Amundi now owns 6,191,871 shares of the healthcare conglomerate's stock worth $1,904,372,000 after purchasing an additional 1,565,245 shares during the period. Institutional investors own 87.86% of the company's stock. <h2>Analysts Set New Price Targets</h2>UNH has been the topic of a number of research reports. Zacks Research upgraded shares of UnitedHealth Group from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Monday, October 6th. KeyCorp lifted their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft downgraded shares of UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $333.00 target price for the company. in a research note on Wednesday, October 29th. TD Cowen boosted their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a &#34;hold&#34; rating in a research report on Thursday, October 30th. Finally, Bank of America lifted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a &#34;neutral&#34; rating in a research note on Wednesday, October 8th. Seventeen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $385.54.<ul><li>5 Healthcare Names to Watch as Sector Rotation Is in Full Swing</li></ul>Read Our Latest Report on UNH<h2>UnitedHealth Group Stock Down 0.2%</h2>UnitedHealth Group stock opened at $327.41 on Friday. The firm has a market cap of $296.58 billion, a price-to-earnings ratio of 17.09, a PEG ratio of 2.13 and a beta of 0.43. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The stock has a fifty day simple moving average of $336.81 and a two-hundred day simple moving average of $318.19. <ul><li>Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy</li></ul>UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group's revenue for the quarter was up 12.2% on a year-over-year basis. During the same period last year, the company earned $7.15 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year. <h2>UnitedHealth Group Announces Dividend</h2>The business also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a $2.21 dividend. The ex-dividend date was Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group's dividend payout ratio (DPR) is currently 46.14%. <h2>More UnitedHealth Group News</h2>Here are the key news stories impacting UnitedHealth Group this week:<ul> <li>Positive Sentiment: UnitedHealth published external reviews and made previously internal audit findings public as part of a transparency push — a governance move that could restore stakeholder trust over time and reduce regulatory risk. UnitedHealth Published External Reviews as Part of Transparency Push</li> <li>Positive Sentiment: Management released 23 action plans from an independent audit and committed to complete implementation by end of March, showing a clear remediation timeline that investors can monitor. This reduces execution uncertainty if plans are delivered. UnitedHealth Group commits to improvements after independent audit, patient backlash</li> <li>Positive Sentiment: Analysts and outlets are pitching UNH as an attractive dividend/long-term buy for 2026 given scale and cash flow, which could draw income-focused buyers despite near-term volatility. Is UnitedHealth the Single Best Dividend Stock to Buy for 2026?</li> <li>Neutral Sentiment: Reuters reports the company will standardize and automate processes in its health services and pharmacy units — likely to improve efficiency long term but may cause near-term implementation costs. UnitedHealth pledges operational changes after external audits</li> <li>Neutral Sentiment: Coverage is reframing UNH’s trajectory as “back to basics” for 2026 and re-evaluating valuation after a steep multi-quarter decline — helpful context but not immediate catalysts. How UnitedHealth will be getting 'back to basics' in 2026</li> <li>Neutral Sentiment: Analyst writeups and comparison pieces (e.g., UNH vs. Eli Lilly) are prompting renewed investor debate on whether UNH’s pullback creates a buying opportunity or signals deeper secular concerns. Better Buy in 2026: UnitedHealth Group or Eli Lilly?</li> <li>Neutral Sentiment: Recent Chinese-language market updates and stock-commentary pieces summarize analyst views and outlooks ahead of year-end — useful for sentiment tracking but not new catalysts. UnitedHealth Group (UNH) Stock Update: Insights and Analyst Predictions Ahead of December 18, 2025 UNH Stock's Transition From Stability To Growth</li> <li>Negative Sentiment: Patient backlash and the breadth of issues revealed by audits have hurt sentiment and could invite closer regulatory scrutiny or legal risk, pressuring the stock near term. UnitedHealth Group commits to improvements after independent audit, patient backlash</li> <li>Negative Sentiment: UNH has endured a steep 2025 drawdown (~35% YTD), prompting valuation re‑ratings and increased volatility — a macro reason some investors are selling rather than buying the remediation story. Is UnitedHealth the Single Best Dividend Stock to Buy for 2026?</li> </ul><h2>About UnitedHealth Group</h2> (Free Report)UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets. UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.<h2>Featured Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Investing In Automotive Stocks</li><li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li><li>How Technical Indicators Can Help You Find Oversold Stocks </li><li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li><li>What Investors Need to Know to Beat the Market</li><li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li></ul>Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).<img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.<h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>Before you consider UnitedHealth Group, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here </div>

Focused Wealth Management Inc increased its holdings in UnitedHealth Group by 161.8% in Q3, now owning 6,756 shares worth $2.33 million. Other major investors like Geode Capital, Norges Bank, and Dodge & Cox also adjusted their stakes. Analysts have mixed ratings on UNH, with a consensus price target of $385.54. UNH reported Q3 earnings of $2.92 per share, beating estimates, with revenue of $113.16 billion. The stock has a market cap of $296.58 billion and a P/E ratio of 17.09.

Focused Wealth Management Inc Grows Stock Holdings in UnitedHealth Group Incorporated $UNH